Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting.
Amritpal SinghAref A Al-KaliJames M ForanMichelle A ElliottKebede H BegnaTalha BadarNandita KheraFarah FletiMaymona AbdelmagidKareen K ReichardRhett P KetterlingAnimesh D PardananiNaseema GangatAyalew TefferiPublished in: American journal of hematology (2022)